Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.
Aker BioMarine ASA's operating assets for the quarter that ended in Jun. 2026 was kr3,616 Mil. Aker BioMarine ASA's operating liabilities for the quarter that ended in Jun. 2026 was kr540 Mil. Aker BioMarine ASA's Total Assets for the quarter that ended in Dec. 2025 was kr3,931 Mil. Therefore, Aker BioMarine ASA's scaled net operating assets (SNOA) for the quarter that ended in Jun. 2026 was 0.78.
Aker BioMarine ASA Scaled Net Operating Assets Related Terms
Aker BioMarine ASA Scaled Net Operating Assets Historical Data
* Premium members only.
The historical data trend for Aker BioMarine ASA's Scaled Net Operating Assets can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Aker BioMarine ASA Scaled Net Operating Assets Chart
OSL:AKBM vs KHC, GIS, HRL: Scaled Net Operating Assets Comparison
For the Packaged Foods subindustry, Aker BioMarine ASA's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Aker BioMarine ASA Scaled Net Operating Assets vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Aker BioMarine ASA's Scaled Net Operating Assets distribution charts can be found below:
* The bar in red indicates where Aker BioMarine ASA's Scaled Net Operating Assets falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Scaled Net Operating Assets of 0.78 mean?
Aker BioMarine ASA (OSL:AKBM) has a Scaled Net Operating Assets of 0.78 as of Jun. 2026. Scaled net operating assets equals current-period operating assets less operating liabilities less prior-period total assets. View historical data on Aker BioMarine ASA and its competitors.
Is Aker BioMarine ASA's Scaled Net Operating Assets too high?
Aker BioMarine ASA's current Scaled Net Operating Assets is 0.78. Overall, Aker BioMarine ASA has a GF Score™ of 64/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Aker BioMarine ASA's Scaled Net Operating Assets compare to KHC and GIS?
Aker BioMarine ASA's Scaled Net Operating Assets of 0.78 can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Scaled Net Operating Assets for a Consumer Packaged Goods company?
A good Scaled Net Operating Assets depends on the Consumer Packaged Goods industry context. However, Scaled Net Operating Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Scaled Net Operating Assets mean?
A high Scaled Net Operating Assets can signal that a stock is expensive relative to its fundamentals. Scaled net operating assets equals current-period operating assets less operating liabilities less prior-period total assets. View historical data on Aker BioMarine ASA and its competitors. Aker BioMarine ASA's current Scaled Net Operating Assets is 0.78. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aker BioMarine ASA stock overvalued right now?
Based on GuruFocus' analysis, Aker BioMarine ASA (OSL:AKBM) is currently considered Significantly Overvalued. The stock's GF Value™ is kr74.55, compared to a current price of kr109.00 — trading 46.2% above its estimated fair value. The current Scaled Net Operating Assets is 0.78. Aker BioMarine ASA's overall GF Score™ is 64/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Scaled Net Operating Assets calculated?
Scaled Net Operating Assets is calculated from a company's financial statements. For Aker BioMarine ASA (OSL:AKBM), the current Scaled Net Operating Assets is 0.78 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Aker BioMarine ASA (OSL:AKBM) Overvalued in 2026?
Based on GuruFocus' analysis, Aker BioMarine ASA stock appears to be overvalued.
The current stock price of kr109.00 is trading 46.2% above its estimated GF Value™ of kr74.55.
GuruFocus considers Aker BioMarine ASA to be Significantly Overvalued.
Key valuation signals for OSL:AKBM:
Scaled Net Operating Assets: 0.78
GF Value™: kr74.55 vs. price of kr109.00 (46.2% above fair value)
No single metric tells the full story. See the OSL:AKBM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Aker BioMarine ASA is a supplier of krill-derived products, with a fully owned supply chain. The operations of the company span from harvesting krill in Antarctica with vessels owned by the company including distribution from Uruguay, and further processing of the krill into oil products in the United States. The segments of the company include Human Health Ingredients, Consumer Health Products, and Emerging Businesses. The company generates the majority of its revenue from the Human Health Ingredients segment, which includes Superba, Lysoveta, PL+ Algae, and the company's Houston manufacturing plant. The segment sells B2B krill oil supplements to nutritional brands for humans around the world.
64GF Score
Get the complete analysis for OSL:AKBM
Scaled Net Operating Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSL:AKBM has been successfully added to your 
